Auris Medical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Auris Medical and buy or sell other stocks, ETFs, and their options commission-free!About EARS
Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the Switzerland and Australia geographical segments.
CEOThomas Meyer, PhD
CEOThomas Meyer, PhD
Employees13
Employees13
HeadquartersHamilton, Hamilton
HeadquartersHamilton, Hamilton
Founded2003
Founded2003
Employees13
Employees13
EARS Key Statistics
Market cap18.35M
Market cap18.35M
Price-Earnings ratio-0.08
Price-Earnings ratio-0.08
Dividend yield—
Dividend yield—
Average volume4.85K
Average volume4.85K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.6248
52 Week high$0.6248
52 Week low$0.0501
52 Week low$0.0501
Stock Snapshot
With a market cap of 18.35M, Auris Medical(EARS) trades at $3.21. The stock has a price-to-earnings ratio of -0.08.
On 2025-12-20, Auris Medical(EARS) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 4.85K.
Over the past 52 weeks, Auris Medical(EARS) stock has traded between a high of $0.62 and a low of $0.05.
Over the past 52 weeks, Auris Medical(EARS) stock has traded between a high of $0.62 and a low of $0.05.